Corbus Pharmaceuticals Holdings Stock Price. Everything You Need To Know About The Corbus Pharmaceuticals Holdings Stock!
Corbus Pharmaceuticals Holdings, Inc. is a pharmaceutical company based in Norwood, Massachusetts, that is currently in phase 3 of clinical trials. The company focuses on developing and commercializing novel therapeutics to treat rare, chronic, and serious inflammatory and fibrotic diseases. Corbus Pharmaceuticals has 33 full-time employees and went public on October 24th, 2014.
The company is engaged in developing and commercializing therapeutics for autoimmunity, fibrosis, and cancer. Its internal development pipeline includes CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, and CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGFβ expressed on cancer cells.
Corbus Pharmaceuticals has also developed CRB-913, a second-generation cannabinoid receptor type 1 (CB1) inverse agonist designed to treat obesity and related metabolic diseases. The CRB-913 program is currently in the pre-clinical stage. The company’s subsidiary includes Corbus Pharmaceuticals, Inc., Corbus International Limited, and Corbus Pharmaceuticals Australia Pty Ltd.
The company’s focus on developing therapeutics to treat rare, chronic, and serious inflammatory and fibrotic diseases highlights its potential for growth. However, investing in clinical-stage pharmaceutical companies like Corbus Pharmaceuticals involves risks and should be carefully considered. Keeping an eye on the stocks share price today and premarket movements can also provide insights into the company’s financial health. Seeking the advice of a financial professional is always recommended before making any investment decisions.
Corbus Pharmaceuticals Holdings Stock Price. Everything You Need To Know About The Corbus Pharmaceuticals Holdings Stock! performance
- Employees 33
- Company HQ Norwood
- Website https://www.corbuspharma.com/
- CRBP Asset Type Common Stock
- CRBP Market Capitalization 367M
- Earnings Per Share -10.31
- Dividends Per Share None
- Dividend Date None
- Quarterly Earnings Growth 0
Are you a retail investor from Malaysia, Thailand, Indonesia, or Vietnam looking to invest in the stock market? Look no further! At Zorion, we provide the investment insights and recommendations you need to make informed decisions about your investments. One stock that has caught the attention of many investors is Corbus Pharmaceuticals Holdings. Corbus Pharmaceuticals Holdings is a promising investment opportunity in the healthcare sector. As a clinical-stage pharmaceutical company, Corbus is dedicated to developing transformative medicines for inflammatory and fibrotic diseases. With their cutting-edge research and development, it’s no wonder why investors are clamoring to get in on this stock. But how do you invest in Corbus Pharmaceuticals Holdings from Malaysia, Thailand, Indonesia, or Vietnam? At Zorion, we make it easy for you. Our user-friendly investment platform allows you to invest in real US stocks and Pre-IPO companies hassle-free. Plus, we offer a wealth of educational resources and materials to further enhance your investment knowledge. Don’t miss out on the opportunity to invest in Corbus Pharmaceuticals Holdings. Join Zorion today and take advantage of our investment insights and recommendations. Start your investment journey with us and make informed decisions that can shape your financial future.
